In vitro activity of ceftazidime/avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from Middle Eastern and African countries: ATLAS global surveillance programme 2015–18

OBJECTIVES: To assess the in vitro activity of ceftazidime/avibactam against a recent, 2015–18, collection of clinical isolates of Gram-negative bacilli from Middle Eastern and African countries with a focus on isolates from ICUs and with MDR and difficult-to-treat resistance (DTR) phenotypes. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlowsky, James A, Bouchillon, Samuel K, El Mahdy Kotb, Ramy, Mohamed, Naglaa, Stone, Gregory G, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251253/
https://www.ncbi.nlm.nih.gov/pubmed/34223129
http://dx.doi.org/10.1093/jacamr/dlab067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251253/
https://www.ncbi.nlm.nih.gov/pubmed/34223129
http://dx.doi.org/10.1093/jacamr/dlab067

Ejemplares similares